title: Drug-Related Inadvertent Deaths in a University Hospital--A Declining Trend.
abstract: We studied the incidence of fatal adverse drug reactions (ADRs) in a tertiary hospital to find out which drugs were involved. The secondary objective was to compare the data from the same hospital published 12 years earlier. All 1708 death cases in the Helsinki University Central Hospital during the year 2012 were retrospectively evaluated. All suspected drug-related deaths, excluding suicides, were scrutinized by an expert panel using the WHO ADR probability classification. Of all cases, 52 (3.0%) were classified as certainly or probably drug related and 24 (1.4%) as possibly drug related. Together, these corresponded to 0.02% of all hospital admissions. The most commonly involved drugs in certain or probable cases were cytostatics (18 cases, 1.1% of all cases) and antithrombotics (17, 1.0%). Twelve years earlier, these caused 27 (1.8%) and 22 (1.5%) cases, respectively. Non-steroidal anti-inflammatory drugs (NSAIDs) and glucocorticoids caused less (2 and 0 cases) fatal ADRs than earlier (12 and 4 cases, p = 0.048 and p = 0.005, respectively). Most of the ADRs leading to death were present already in admission and affected seriously ill or elderly patients. Hospital-born fatal ADRs occurred in 0.003% of patients. In conclusion, cytostatics and antithrombotics are still the leading causes of fatal ADRs, but NSAIDs and glucocorticoids seem to cause fatal ADRs less often than previously. The incidence of fatal ADRs in 2012 was 3.0% of all deaths, suggesting a decline compared to the 2000 value (5.0%). Improved awareness, prevention and treatment of ADRs and safer medicines may explain these declining trends.
authors.affiliation: Department of Clinical Pharmacology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
authors.forename: Outi
authors.initials: O
authors.lastname: Lapatto-Reiniluoto
authors.affiliation: Department of Clinical Pharmacology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
authors.forename: Laura
authors.initials: L
authors.lastname: Patinen
authors.affiliation: Department of Clinical Pharmacology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
authors.forename: Mikko
authors.initials: M
authors.lastname: Niemi
authors.affiliation: Department of Clinical Pharmacology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
authors.forename: Janne T
authors.initials: JT
authors.lastname: Backman
authors.affiliation: Department of Clinical Pharmacology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
authors.forename: Pertti J
authors.initials: PJ
authors.lastname: Neuvonen
mesh_terms: D000368:Aged; D064420:Drug-Related Side Effects and Adverse Reactions / Q000175:diagnosis / Q000401:mortality* / Q000517:prevention & control; D005260:Female; D005387:Finland; D017052:Hospital Mortality / Q000639:trends*; D006785:Hospitals, University / Q000639:trends*; D006801:Humans; D015994:Incidence; D008297:Male; D012189:Retrospective Studies; D018570:Risk Assessment; D012307:Risk Factors; D013405:Suicide / Q000639:trends*; D013997:Time Factors; D000092864:Suicide Prevention